No Data
Express News | Gossamer Bio to Provide Updated Seralutinib Torrey Open-Label Extension Data at the American Thoracic Society 2024 International Conference
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday's after-market session. The market value of their outstanding shares is at $27.0 million. Harrow (NASDAQ
Express News | Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Chiesi Y Gossamer Bio Anuncian Una Colaboración Global Para Desarrollar Y Comercializar Seralutinib
Chiesi y Gossamer Bio anuncian una colaboración global transformadora para desarrollar y comercializar seralutinib en la hipertensión arterial pulmonar y otras indicaciones respiratorias Colaborac
Chiesi Et Gossamer Bio Annoncent Une Collaboration Mondiale Transformatrice Pour Développer Et Commercialiser Le Séralutinib Pour L'hypertension Artérielle Pulmonaire Et D'autres Indications Respiratoires
Collaboration stratégique pour tirer parti de l'héritage de leadership dans les maladies respiratoires de Chiesi et de l'expertise de Gossamer Bio en matière de développement pour l'hypertension
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PDF Version SAN DIEGO--(BUSINESS WIRE)--May 10, 2024-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutini